Not provided
Not provided
Not provided
Not provided
Not provided
Lack of efficacy
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease.
The purpose of the study is to demonstrate the intended use of the Gatekeeper Reflux Repair System to provide symptomatic relief is subjects with gastroesophageal reflux disease
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sham | Sham Comparator | This arm of the study has the procedure but does not get the Gatekeeper prostheses. The Sham arm has the option to cross-over to the Treatment arm at the 6-month visit. |
|
| Treatment | Active Comparator | The treatment arm has the Gatekeeper devices implanted. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Gatekeeper Reflux Repair System | Device | The Gatekeeper Systemâ„¢ consists of a specialized 16-mm overtube assembly, a 2.4-mm diameter prosthesis delivery system (1-mm diameter needle, dilator, and 2.4-mm diameter sheath), a pushrod assembly and Gatekeeper Prosthesis. Up to 4 prostheses will be implanted at the initial procedure and retreatment with up to four more prostheses will be allowed at 3-months if the subject has a GERD HRQL score >15. |
| Measure | Description | Time Frame |
|---|---|---|
| Reduction in serious device and procedure related adverse device effects. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Improvement in espophageal pH | 6 months |
Not provided
Diagnosis and main criteria for inclusion:
Diagnosis and main criteria for exclusion:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Glen Lehman | Indiana University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Contact Medtronic for specific site information | San Francisco | California | 94115 | United States | ||
| Contact Medtronic for specific site information |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Atlanta |
| Georgia |
| 30322 |
| United States |
| Contact Medtronic for specific site information | Chicago | Illinois | 60611 | United States |
| Contact Medtronic for specific site information | Indianapolis | Indiana | 46202 | United States |
| Contact Medtronic for specific site information | Lexington | Kentucky | 40536 | United States |
| Contact Medtronic for specific site information | St Louis | Missouri | 63110 | United States |
| Contact Medtronic for specific site information | Lebanon | New Hampshire | 03756 | United States |
| Contact Medtronic for specific site information | New York | New York | 10021 | United States |
| Contact Medtronic for specific site information | Knoxville | Tennessee | 37909 | United States |
| Contact Medtronic for specific site information | Milwaukee | Wisconsin | 53233 | United States |
| Contact Medtronic for specific site information | Amsterdam | Netherlands |
| ID | Term |
|---|---|
| D005764 | Gastroesophageal Reflux |
| ID | Term |
|---|---|
| D015154 | Esophageal Motility Disorders |
| D003680 | Deglutition Disorders |
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided